KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organon (OGN) EBT Margin (2020 - 2025)

Historic EBT Margin for Organon (OGN) over the last 6 years, with Q3 2025 value amounting to 15.17%.

  • Organon's EBT Margin rose 20800.0% to 15.17% in Q3 2025 from the same period last year, while for Sep 2025 it was 18.74%, marking a year-over-year decrease of 21000.0%. This contributed to the annual value of 20.08% for FY2024, which is 4900.0% up from last year.
  • As of Q3 2025, Organon's EBT Margin stood at 15.17%, which was up 20800.0% from 14.37% recorded in Q2 2025.
  • Organon's 5-year EBT Margin high stood at 41.18% for Q4 2023, and its period low was 5.27% during Q3 2023.
  • Moreover, its 5-year median value for EBT Margin was 15.8% (2023), whereas its average is 20.74%.
  • Its EBT Margin has fluctuated over the past 5 years, first plummeted by -186000bps in 2021, then soared by 231200bps in 2022.
  • Quarter analysis of 5 years shows Organon's EBT Margin stood at 14.72% in 2021, then surged by 157bps to 37.85% in 2022, then increased by 9bps to 41.18% in 2023, then dropped by -7bps to 38.19% in 2024, then plummeted by -60bps to 15.17% in 2025.
  • Its EBT Margin was 15.17% in Q3 2025, compared to 14.37% in Q2 2025 and 6.68% in Q1 2025.